558 related articles for article (PubMed ID: 10673674)
1. Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation - a compassionate use experience.
DeVincenzo JP; Hirsch RL; Fuentes RJ; Top FH
Bone Marrow Transplant; 2000 Jan; 25(2):161-5. PubMed ID: 10673674
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients.
Whimbey E; Champlin RE; Englund JA; Mirza NQ; Piedra PA; Goodrich JM; Przepiorka D; Luna MA; Morice RC; Neumann JL
Bone Marrow Transplant; 1995 Sep; 16(3):393-9. PubMed ID: 8535312
[TBL] [Abstract][Full Text] [Related]
3. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin.
Ghosh S; Champlin RE; Englund J; Giralt SA; Rolston K; Raad I; Jacobson K; Neumann J; Ippoliti C; Mallik S; Whimbey E
Bone Marrow Transplant; 2000 Apr; 25(7):751-5. PubMed ID: 10745261
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy of respiratory syncytial virus pneumonia following bone marrow transplantation.
De Vincenzo JP; Leombruno D; Soiffer RJ; Siber GR
Bone Marrow Transplant; 1996 Jun; 17(6):1051-6. PubMed ID: 8807113
[TBL] [Abstract][Full Text] [Related]
5. An outbreak of respiratory syncytial virus infection in a bone marrow transplant unit: effect on engraftment and outcome of pneumonia without specific antiviral treatment.
Abdallah A; Rowland KE; Schepetiuk SK; To LB; Bardy P
Bone Marrow Transplant; 2003 Jul; 32(2):195-203. PubMed ID: 12838285
[TBL] [Abstract][Full Text] [Related]
6. Respiratory syncytial virus infection outbreak among pediatric patients with oncologic diseases and/or BMT.
Anak S; Atay D; Unuvar A; Garipardic M; Agaoglu L; Ozturk G; Karakas Z; Devecioglu O
Pediatr Pulmonol; 2010 Mar; 45(3):307-11. PubMed ID: 20146398
[TBL] [Abstract][Full Text] [Related]
7. Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections.
Sparrelid E; Ljungman P; Ekelöf-Andström E; Aschan J; Ringdén O; Winiarski J; Wåhlin B; Andersson J
Bone Marrow Transplant; 1997 May; 19(9):905-8. PubMed ID: 9156264
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of respiratory syncytial virus infections in immunocompromised hematological patients].
Thorsen S; Hornsleth AK; Pedersen BK; Heilmann CJ
Ugeskr Laeger; 2000 Aug; 162(35):4644-7. PubMed ID: 10986889
[TBL] [Abstract][Full Text] [Related]
9. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
Chávez-Bueno S; Mejías A; Merryman RA; Ahmad N; Jafri HS; Ramilo O
Pediatr Infect Dis J; 2007 Dec; 26(12):1089-93. PubMed ID: 18043443
[TBL] [Abstract][Full Text] [Related]
10. Respiratory syncytial virus infection following hematopoietic stem cell transplantation.
Small TN; Casson A; Malak SF; Boulad F; Kiehn TE; Stiles J; Ushay HM; Sepkowitz KA
Bone Marrow Transplant; 2002 Feb; 29(4):321-7. PubMed ID: 11896429
[TBL] [Abstract][Full Text] [Related]
11. Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature.
Khanna N; Widmer AF; Decker M; Steffen I; Halter J; Heim D; Weisser M; Gratwohl A; Fluckiger U; Hirsch HH
Clin Infect Dis; 2008 Feb; 46(3):402-12. PubMed ID: 18181739
[TBL] [Abstract][Full Text] [Related]
12. Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins.
Ghosh S; Champlin RE; Ueno NT; Anderlini P; Rolston K; Raad I; Kontoyiannis D; Jacobson K; Luna M; Tarrand J; Whimbey E
Bone Marrow Transplant; 2001 Aug; 28(3):271-5. PubMed ID: 11535995
[TBL] [Abstract][Full Text] [Related]
13. A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients.
Liu V; Dhillon GS; Weill D
Transpl Infect Dis; 2010 Feb; 12(1):38-44. PubMed ID: 19761558
[TBL] [Abstract][Full Text] [Related]
14. Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host.
Wendt CH; Hertz MI
Semin Respir Infect; 1995 Dec; 10(4):224-31. PubMed ID: 8668850
[TBL] [Abstract][Full Text] [Related]
15. Respiratory syncytial virus infection in the late bone marrow transplant period: report of three cases and review.
Khushalani NI; Bakri FG; Wentling D; Brown K; Mohr A; Anderson B; Keesler C; Ball D; Bernstein ZP; Bernstein SH; Czuczman MS; Segal BH; McCarthy PL
Bone Marrow Transplant; 2001 May; 27(10):1071-3. PubMed ID: 11438823
[TBL] [Abstract][Full Text] [Related]
16. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections.
American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn
Pediatrics; 2003 Dec; 112(6 Pt 1):1442-6. PubMed ID: 14654627
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group.
Groothuis JR; Simoes EA; Levin MJ; Hall CB; Long CE; Rodriguez WJ; Arrobio J; Meissner HC; Fulton DR; Welliver RC
N Engl J Med; 1993 Nov; 329(21):1524-30. PubMed ID: 8413475
[TBL] [Abstract][Full Text] [Related]
18. Pre-emptive use of aerosolized ribavirin in the treatment of asymptomatic pediatric marrow transplant patients testing positive for RSV.
Adams R; Christenson J; Petersen F; Beatty P
Bone Marrow Transplant; 1999 Sep; 24(6):661-4. PubMed ID: 10490733
[TBL] [Abstract][Full Text] [Related]
19. Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome.
Avetisyan G; Mattsson J; Sparrelid E; Ljungman P
Transplantation; 2009 Nov; 88(10):1222-6. PubMed ID: 19935377
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of RSVIG prophylaxis and therapy of respiratory syncytial virus in an immunosuppressed animal model.
Ottolini MG; Porter DD; Hemming VG; Zimmerman MN; Schwab NM; Prince GA
Bone Marrow Transplant; 1999 Jul; 24(1):41-5. PubMed ID: 10435733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
